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Despite the development in the identiﬁcation of Nocardia spp., common
challenges exist in the laboratory diagnosis and management of nocardiosis. We report
two cases of disseminated nocardiosis in a patient with hematologic disorder and in a
patient with systemic lupus erythematosus, where the cooperation between various
specialists was essential to set up the adequate diagnosis of disseminated nocardiosis.
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Introduction
Nocardia species are ubiquitous environmental ﬁlamentous bacteria that
may cause various infections in humans [1]. The incidence of these infections has
increased among immunocompromised patients in the last three decades, because
of widespread use of immunosuppressive therapy and modern microbiological
diagnostic procedures. In spite of the increasing number of these infections and the
development in identiﬁcation of Nocardia spp., the laboratory diagnosis and
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management of nocardiosis are quite difﬁcult, and probably nocardiosis is under-
diagnosed [2]. Development of infection is mainly due to inhalation or cutaneous
inoculation of this pathogen. Nosocomial infection is rarely detected. Several
conditions predispose to nocardiosis, such as corticosteroid therapy, malignant
hematological diseases, chronic pulmonary disease, and bone marrow and solid
organ transplantations. In immunocompromised host, hematogenous dissemina-
tion, involving the central nervous system (CNS) and skin, is characteristic. In
this patient group, morbidity and mortality are high because of the patient’s




A 37-year-old man was diagnosed with large granular lymphocytic leuke-
mia in 1998. He underwent six cycles of combined chemotherapeutic treatment
(cytoxan, vincristine, and prednisolone), and later had long-term steroid therapy
due to Coombs positive hemolytic anemia and active hemolytic events. He was
hospitalized due to several febrile episodes 6 months before the present admission,
but infectious agents could not be detected. Upon admission, the patient com-
plained of generalized fatigue, fever, and vomiting. On physical examination, the
patient’s blood pressure was 130/90 mmHg and his heart rate was 104 beats/min.
After hospital admission, headache and dizziness started. Neurological examina-
tion did not reveal any signs of meningitis. Serum laboratory results showed
normal level of procalcitonine, liver and kidney function, elevated leukocyte count
(34.2 g/L) with 80% neutrophil cells, mild anemia (hemoglobin level 11.3 g/L),
and normal platelet count (339 g/L). Three days later, computed tomography (CT)
was done because of central type paresis of facial and hypoglossal nerves. The CT
scan showed multiple lesions (6–13 mm in diameter) with perifocal edema.
Stereotactic core biopsy from lesions could not be performed because of deterio-
ration in the patient’s clinical status. Blood and urine samples for bacteriological
culture were collected, and empiric antibiotic therapy (imipenem–cilastatin 500mg
every 6 h) was started. Two blood culture bottles gave positive signal after 52 and
65 h of incubations, and in the Gram-stained preparations, Gram-positive branch-
ing ﬁlaments could be observed (Figure 1A). After 24 h of incubation in 5% CO2
atmosphere, small colonies were grown. Because of unsuccessful identiﬁcation of
the isolated strains using commercial kit (VITEK 2 GP ID card, bioMérieux,
Marcy-l’Étoile, France), 16S rDNA sequencing was performed. Nucleic acid from
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the colonies was puriﬁed using QIAamp DNA mini kit (Qiagen) and the 16S
rDNAwas ampliﬁed using previously published primers (E8F and E533R) [4]. On
the basis of sequence analysis of the ampliﬁed polymerase chain reaction (PCR)
product, Nocardia farcinica was identiﬁed. The patient died due to septic episode
2 days later and autopsy was not performed.
Case 2
A 21-year-old man with systemic lupus erythematosus (SLE) was hospital-
ized in the Clinics of Rheumatology because of fever, cough, and dyspnea. The
disease had been diagnosed on the basis of arthralgias, anemia, leucopenia,
proteinuria, low C3 complement level, anti-dsDNA antibody positivity, and
biopsy proven diffuse-global active lupus glomerulonephritis 3 months before the
present admission. Methylprednisolone was given (250 mg/day intravenously),
and dosage was gradually reduced to 16 mg/day after achieving remission. Shortly
Figure 1. (A) Gram-positive branching ﬁlaments from blood culture (1,000× magniﬁcation);
(B) Gram-positive branching ﬁlaments from endotracheal aspirate (1,000× magniﬁcation);
(C) N. farcinica (small colonies) and N. cyriacigeorgica (white colonies) could be cultured from
endotracheal aspirate; (D) subpleural abscess (diameter 2 cm) in the lung; (E) Grocott staining of the
pulmonary abscess demonstrates branching bacterial ﬁlaments, corresponding to Nocardia infection
(original magniﬁcation, 40×)
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after the present admission, the patient was transferred to the ICU because of
multi-organ failure, bilateral pneumonia, and suspicion of lung abscess. Empiric
intravenous antibiotic (4.5 g of piperacillin/tazobactam 3 times/day, 1 g of
amikacin daily, and 1 g of vancomycin twice/day), and antifungal (amphotericin
B 50 mg/day) therapies were started after sample collection for microbiological
culture (blood culture and endotracheal aspirate). Laboratory results showed
elevated white blood cell (14.09 g/L with 90% neutrophil granulocytes) and
C-reactive protein (327 mg/L). In the Gram-stained preparation of the endotra-
cheal specimens, Gram-positive branching ﬁlaments with the presence of gran-
ulocytes were observed (Figure 1B). On the basis of this ﬁnding, antibiotic therapy
was completed with trimethoprim/sulfhamethoxazole. After 72 h of incubation,
small and white colonies were cultured (Figure 1C). Because of unsuccessful use
of commercial identiﬁcation system (VITEK 2 GP ID card, bioMérieux), DNA
was isolated from two types of colonies, and 16S rDNA sequencing was
performed using the above-mentioned primers. On the basis of the sequence of
the ampliﬁed PCR products, in case of small colonies, N. farcinica, whereas in
case of white colonies, Nocardia cyriacigeorgica were identiﬁed. Vasopressor
therapy and mechanical ventilation were introduced because of hypotension and
respiratory failure. His renal function was worsened, thus renal dialysis was
started. On the basis of antimicrobial susceptibility testing (E-test, AB Biodisk,
Solna, Sweden), N. farcinica and N. cyriacigeorgica were susceptible to imipenem
and amikacin; thus, antibiotic therapy was changed to imipenem–amikacin combi-
nation. Blood culture bottles also gave positive signal after 52 h of incubation, and
N. farcinica with the same susceptibility pattern was grown from the blood. During
the antibiotic therapy, the number of bacteria in the endotracheal aspirates was
reduced from >105 CFU/mL to 102 CFU/mL in the case of N. farcinica, whereas N.
cyriacigeorgica was not detected from the subsequent respiratory specimens. After
temporary improvement in the patient’s condition, deteriorations in SLE and adult
respiratory distress syndrome (ARDS) have been observed again. Following a 19-
day stay in ICU, the patient died due to multi-organ failure.
The autopsy demonstrated multiple, 0.5–1.5 cm sized abscesses in the lungs
(Figure 1D), mainly at the periphery, and an abscess of 4 cm in diameter in the
right upper lobe. The kidneys were abnormally swollen and 4–6 (0.5–0.8 mm
sized) abscesses were encountered in the cortex. Histologically, the abscesses were
characterized by widespread suppuration and necrosis, a few epithelioid cells at
the margins and the absence of a pyogenic membrane. The Grocott staining
revealed long, thin, and beaded bacterial ﬁlaments, sometimes branching in right
angles (Figure 1E). In the areas neighboring pulmonary abscesses, diffuse alveolar
damage with hyaline membranes was noted. The ﬁndings corresponded to a
Nocardia infection of the lungs and kidneys, and ARDS. Since the activity lesions
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of lupus glomerulonephritis had almost disappeared, the therapy of lupus nephritis
proved to be effective. The cause of deterioration of the patient’s status was the
Nocardia infection, not controlled efﬁciently by the antibiotic treatment.
Conclusions
Nocardiosis is most frequently described as opportunistic infection in im-
munocompromised patients, especially, in patients with depressed cell-mediated
immunity. Pulmonary nocardiosis is the most common clinical presentation of
this infection, while among extrapulmonary forms, CNS involvement is quite
common [1, 5, 6]. Bacteremia caused by Nocardia spp. is rarely described clinical
entity, and in the majority of patients, concurrent pulmonary (64%), cutaneous
(28%), and CNS involvements (19%) could be observed [6]. In the case of
disseminated nocardiosis, two or more organs are infected, and in the majority of
cases, due to airway transmission, the lung is also affected. In case 1, this could not
be conﬁrmed radiologically and the patient did not have any respiratory symp-
toms, whereas in case 2, the patient had severe respiratory symptoms and later
autopsy conﬁrmed nocardial infection of lungs and kidneys. Several publications
showed case reports about the presence of N. farcinica in various infections, but
according to Christidou et al. [7] until 2004, only 11 English publications were
found where N. farcinica bacteremia was described.
During the last 20 years, because of the development in microbiological
methods, several changes could be observed in the taxonomy of genus Nocardia,
thus we can get more adequate data about the prevalence and the role of certain
species in various clinical pictures. On the basis of literature data, N. farcinica and
N. cyriacigeorgica are increasingly reported in human infections [5]. These
species are associated with pulmonary and extrapulmonary forms of nocardiosis;
in addition to these, N. farcinica has emerged as a nosocomial pathogen, while the
detection of N. farcinica from blood is rare [5, 8]. Christidou et al. [7] reported a
case of fatal N. farcinica bacteremia in a patient with lung cancer, and they found
only 11 previously reported cases, in English literature. The majority of patients
were male and had one or more predisposing factors, and the lung was the most
common primary site of infection. The mortality rate was 41.7%; similarly, poor
outcome associated with N. farcinica was previously reported by Torres et al. [9].
General treatment recommendations for nocardiosis are difﬁcult to establish due to
the lack of controlled trials and variable in vitro antibiotic susceptibility patterns
[6]. In addition to these, it is difﬁcult to perform antimicrobial susceptibility testing
because of the slow growing nature of several Nocardia spp., inoculum consis-
tency, and interpretation of cutoff [10]. The treatment of N. farcinica infections is
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also problematic, because the majority of clinical isolates are multi-resistant; thus,
in our case, the isolated strain was only susceptible to imipenem and amikacin.
Here, we have described two cases of nocardiosis in immunocompromised
hosts. In the ﬁrst case, we supposed that multiple lesions caused by Nocardia spp.
on the basis of CT scan, signs, and blood culture isolate. Peculiarity of the second
case was that two Nocardia spp. could be isolated from the respiratory tract, and in
spite of the antibiotic susceptibility results, combination therapy did not cure the
infection. Owing to special culture condition of Nocardia spp., communication
between specialists is essential to successful detection of these pathogens.
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